Literature DB >> 6455611

Rates of chromosome abnormalities at different maternal ages.

E B Hook.   

Abstract

Estimates are made of the rates of all clinically significant cytogenetic abnormalities in live births by 1-year maternal age intervals ranging from 15 to 49. Down syndrome results from the most prevalent clinically significant cytogenetic abnormality, yet the rates of disorders associated with other cytogenetic abnormalities also increase with maternal age and significantly contribute to the overall rate at the older ages. The estimated rate of all clinically significant cytogenetic abnormalities rises from about 2 per 1000 (1 per 500) at the youngest maternal ages to about 2.6 per 1000 (1 per 270) at age 30, 5.6 per 1000 (1 per 80) at age 35, 15.8 per 1000 (1 per 60) at age 40, and 53.7 per 1000 (1 per 20) at age 45.

Mesh:

Year:  1981        PMID: 6455611

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  66 in total

1.  Down's syndrome: the effects of prenatal diagnosis and demographic factors in a region of the eastern part of Germany.

Authors:  C Rösch; V Steinbicker; S Kropf
Journal:  Eur J Epidemiol       Date:  2000       Impact factor: 8.082

2.  An economic model of amniocentesis choice.

Authors:  Eduardo Fajnzylber; V Joseph Hotz; Seth G Sanders
Journal:  Adv Life Course Res       Date:  2010-03-01

Review 3.  The prenatal diagnosis of genetic diseases.

Authors:  Peter Wieacker; Johannes Steinhard
Journal:  Dtsch Arztebl Int       Date:  2010-12-03       Impact factor: 5.594

4.  Changes in maternal characteristics in Nova Scotia, Canada from 1988 to 2001.

Authors:  Deshayne B Fell; K S Joseph; Linda Dodds; Alexander C Allen; Krista Jangaard; Michiel Van den Hof
Journal:  Can J Public Health       Date:  2005 May-Jun

5.  Adaptive-filtering of trisomy 21: risk of Down syndrome depends on family size and age of previous child.

Authors:  Markus Neuhäuser; Sven Krackow
Journal:  Naturwissenschaften       Date:  2006-09-30

6.  Propensity scores: method for matching on multiple variables in down syndrome research.

Authors:  Jennifer Urbano Blackford
Journal:  Intellect Dev Disabil       Date:  2009-10

7.  Prenatal detection of trisomy 21 and 18 from amniotic fluid by quantitative fluorescent polymerase chain reaction.

Authors:  T Tóth; I Findlay; C Papp; E Tóth-Pál; T Marton; B Nagy; P Quirke; Z Papp
Journal:  J Med Genet       Date:  1998-02       Impact factor: 6.318

8.  Factors that affect the decision to undergo amniocentesis in women with normal Down syndrome screening results: it is all about the age.

Authors:  Julia Grinshpun-Cohen; Talya Miron-Shatz; Liat Ries-Levavi; Elon Pras
Journal:  Health Expect       Date:  2014-05-12       Impact factor: 3.377

Review 9.  The menopause and aging, a comparative perspective.

Authors:  Caleb E Finch
Journal:  J Steroid Biochem Mol Biol       Date:  2013-04-10       Impact factor: 4.292

10.  Rapid prenatal diagnosis of trisomy 21 by real-time quantitative polymerase chain reaction with amplification of small tandem repeats and S100B in chromosome 21.

Authors:  Young Ho Yang; Mi Suk Nam; Eun Suk Yang
Journal:  Yonsei Med J       Date:  2005-04-30       Impact factor: 2.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.